Special Opportunities Fund, Common Stock (PIF) 뉴스

https://x.com/ricknagra/status/1877370533668327653?s=46&t=xLP2LlWgJrEMUZZ7Fum-nA

https://www.theregister.com/AMP/2025/01/09/japan_mirrorface_china_attack/

This could be majorly big news, but I’m not holding my breath yet. Up to this point I’ve been paying for my branded Vascepa through blinks RX $99 a month. I have not been able to get it covered through different insurance plans such as CareFirst Humana, etc. recently changed my insurance to OptumRx

Didn't Missling congratulate Dr. Talavera for making the EMA filing happen in his PR?

https://finance.yahoo.com/news/ensysce-biosciences-issues-annual-shareholder-130000054.html

I have seen sprinklers roofs. And Steel roofing can make a huge difference.


..


.

https://finance.yahoo.com/news/ensysce-biosciences-issues-annual-shareholder-130000054.html

https://www.barchart.com/stocks/quotes/AVXL/competitors?quoteSectors=-283G&viewName=main&orderBy=weightedAlpha&orderDir=desc&page=1
Biopharma tickers under $9
CADL BCRX ENGN RGNX BLUE

........

Blarcamesine in Early Alzheimer Disease Phase 2b/3 Randomized Clinical Trial
Marwan N. Sabbagh, William R. Chezem, Kun Jin, Christopher U Missling, Anavex Life Sciences Research Group
First published: 09 January 2025

Abstract
Background
There are no approve

The CONdog96 🤡™ Fools No One.

Absolutely No One

Thank you mouton, no I did not. I'm utilizing the app on my iPhone.  Had no idea a video was attached to said post.  I rarely if ever use a computer for access to I-Hub.

So you personally know what the Twitter posters are doing and what their account looks like? Got it…. Again, nobody can provide a reason to buy this and neither can the company, hence the share price and lack of volume

The eulogies written by Gerald Ford and Walter Mondale (and delivered by their sons) were really good and apprapro to today.

Jimmy Carter may not have been the best president but he sure as hell was the best person that was ever President.

Bird deaths plummet at McCormick Place Lakeside Center after safety film installed

https://www.chicagotribune.com/wp-content/uploads/2025/01/CTC-L-bird-collisions-improve-27_217660954.jpg?w=1495
Paul Groleau, vice president of Feather Friendly, left, U.S. Fish and Wildlife Serv

Hedging against a loss is good and options are not really complex if used properly...good luck....writing calls for income is useful, buying puts is a way to lock in profits with only risk being the puts expire worthless.

I would pass on the gambling part for leverage though

Perhaps January beat down prior to some Jan 2025 news CES innovation awards 

Key DD timeline of events showing management isn't holding back!

With the name changed approval (as noted yesterday by Fidelity) the OTCQB is NOW close at hand in order to fund the ramp up with Winner, assuming it is even needed.

Funding for production, IF NEEDED:

Assuming an approval decision and no hiccups.

Man, I thought we all got PAST MR OCTOBER, heck I totally forgot about him, now he back , too bad !!!

Very nicely said and sensibilities, thanks for that. Enjoy the snow!.. (novelty as worn right off for me up here lol ;)..
https://x.com/WintersPolitics/status/1877201416248324345

That's cold, but make no mistake, it's "Florida cold" here too...😏 It was in the low 20's in the panhandle.
(We live about 25 miles northeast of Tampa)

Woke up to mid 30's and expect the same tonite and again next week. It is Winter
I suppose🙂
Th

Saw this posted: https://www.reddit.com/r/interestingasfuck/comments/1hwqyt3/two_men_and_a_dog_trapped_as_the_palisades_fire/

It appears that the house has a system that you asked about. Water is falling off the roof.

The availability of water and electricity to run su

KRTLBIOTECH OTC:KRTL
@KRTLBiotech
·
7h
“Attention $KRTL shareholders: Congratulations on today’s press release announcement! To clarify, our 55% majority stake was acquired by providing access to our valuable APIs, with no dilution on our part.” and idiots sold the news c

https://www.barchart.com/stocks/quotes/AVXL/competitors?quoteSectors=-283G&viewName=main&orderBy=weightedAlpha&orderDir=desc&page=1
Biopharma tickers under $8
AURA RXRX ITOS IOVA